Previous Close | 3.2000 |
Open | 3.2000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 32.00 |
Expire Date | 2024-07-19 |
Day's Range | 3.2000 - 3.2000 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Pfizer (PFE) closed at $27.66 in the latest trading session, marking a -1.32% move from the prior day.
NEW YORK, June 12, 2024--Pfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin gene therapy, fordadistrogene movaparvovec, in ambulatory patients with Duchenne muscular dystrophy (DMD) did not meet its primary endpoint of improvement in motor function among boys 4 to 7 years of age treated with the gene therapy compared to placebo. The primary endpoint in the final ana
Pfizer stock is struggling to retake its 200-day line despite promising updates in cancer treatment. Is PFE stock now a sell?